新規登録 | ログイン | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

zkyken cite [14 articles]

最近 zkyken さんのライブラリに追加された論文の中から タグ cite. You can also see everyone's cite.
  • Prostate cancer: therapeutic, diagnostic, and basic studies.
    Lab Invest, Vol. 67, No. 5. (November 1992), pp. 540-552.
    by ME Stearns, T McGarvey
    posted to cancer cite diagnosis_treatment prostate by zkyken on 2007-06-13 16:19:40 as **
  • Inhibition of Growth Factor Production and Angiogenesis in Human Cancer Cells by ZD1839 (Iressa), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
    Clin Cancer Res, Vol. 7, No. 5. (1 May 2001), pp. 1459-1465.
    by Fortunato Ciardiello, Rosa Caputo, Roberto Bianco, Vincenzo Damiano, Gabriella Fontanini, Sabina Cuccato, Sabino De Placido, Raffaele A Bianco, Giampaolo Tortora
    posted to cancer cite egfr by zkyken on 2007-06-13 15:56:45 as **
  • Studies with CWR22 Xenografts in Nude Mice Suggest That ZD1839 May Have a Role in the Treatment of Both Androgen-dependent and Androgen-independent Human Prostate Cancer
    Clin Cancer Res, Vol. 8, No. 12. (1 December 2002), pp. 3870-3876.
    by Francis M Sirotnak, Yohung She, Fei Lee, Jing Chen, Howard I Scher
    posted to cite egfr fulltext hrpc therapy by zkyken on 2007-06-13 15:54:43 as **
  • Growth factors and their receptors: new targets for prostate cancer therapy.
    Urology, Vol. 58, No. 2 Suppl 1. (August 2001), pp. 114-122.
    by J Barton, G Blackledge, A Wakeling
    posted to cancer cite egfr prostate therapy by zkyken on 2007-06-13 15:52:20 as **
  • Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms
    Clin Cancer Res, Vol. 1, No. 5. (1 May 1995), pp. 545-550.
    by Hi Scher, A Sarkis, V Reuter, D Cohen, G Netto, D Petrylak, P Lianes, Z Fuks, J Mendelsohn, C Cordon-Cardo
    posted to cancer cite egfr fulltext prostate by zkyken on 2007-06-13 15:50:15 as **
  • A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.
    Clin Cancer Res, Vol. 7, No. 10. (October 2001), pp. 2958-2970.
    by F Ciardiello, G Tortora
    posted to cite egfr fulltext by zkyken on 2007-06-13 15:45:07 as **
  • The epidermal growth factor receptor and its inhibition in cancer therapy.
    Pharmacol Ther, Vol. 82, No. 2-3. (n 1999), pp. 241-250.
    by JR Woodburn
    posted to cancer cite egfr by zkyken on 2007-06-13 15:42:53 as **
  • Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
    N Engl J Med, Vol. 351, No. 15. (7 October 2004), pp. 1502-1512.
    by IF Tannock, R de Wit, WR Berry, J Horti, A Pluzanska, KN Chi, S Oudard, C Théodore, ND James, I Turesson, MA Rosenthal, MA Eisenberger,
    posted to cancer cite fulltext hrpc prostate by zkyken on 2007-06-13 15:16:36 as ** along with 1 person zebkhan
  • Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results.
    J Urol, Vol. 172, No. 3. (September 2004), pp. 910-914.
    by KA Roehl, M Han, CG Ramos, JA Antenor, WJ Catalona
    posted to cancer cite hrpc surgery by zkyken on 2007-06-13 15:12:29 as **
  • Natural history of progression after PSA elevation following radical prostatectomy.
    JAMA, Vol. 281, No. 17. (5 May 1999), pp. 1591-1597.
    by CR Pound, AW Partin, MA Eisenberger, DW Chan, JD Pearson, PC Walsh
    posted to cancer cite hrpc prostate by zkyken on 2007-06-13 15:10:27 as **
  • notes The management of hormone refractory prostate cancer.
    Eur Urol, Vol. 29 Suppl 2 (1996), pp. 69-74.
    by DW Newling
    posted to cancer cite hrpc prostate by zkyken on 2007-06-13 15:03:39 as **
  • Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer.
    Oncol Rep, Vol. 15, No. 6. (June 2006), pp. 1453-1460.
    by S Yano, H Matsuyama, H Hirata, R Inoue, H Matsumoto, C Ohmi, K Miura, M Shirai, N Iizuka, K Naito
    posted to cite egfr fulltext hrpc by zkyken on 2007-05-13 09:03:21 as **
  • Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
    Clin Cancer Res, Vol. 11, No. 16. (15 August 2005), pp. 5878-5885.
    by M Taron, Y Ichinose, R Rosell, T Mok, B Massuti, L Zamora, JL Mate, C Manegold, M Ono, C Queralt, T Jahan, JJ Sanchez, M Sanchez-Ronco, V Hsue, D Jablons, JM Sanchez, T Moran
    posted to cite egfr fulltext by zkyken on 2007-05-07 15:43:22 as **
  • Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib.
    Prostate, Vol. 67, No. 6. (1 May 2007), pp. 603-604.
    by G Curigliano, G Pelosi, T De Pas, G Renne, O De Cobelli, M Manzotti, G Spitaleri, F de Braud
    posted to cite egfr hrpc by zkyken on 2007-05-07 15:22:38 as ***** along with 1 person and 1 group cursonivel1 cursonivel1
    • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/user/zkyken/tag/cite

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.